Ma, Feiyang http://orcid.org/0000-0002-6260-0787
Plazyo, Olesya
Billi, Allison C.
Tsoi, Lam C.
Xing, Xianying
Wasikowski, Rachael http://orcid.org/0000-0003-3544-3023
Gharaee-Kermani, Mehrnaz
Hile, Grace
Jiang, Yanyun
Harms, Paul W. http://orcid.org/0000-0002-0802-2883
Xing, Enze http://orcid.org/0000-0001-9358-9368
Kirma, Joseph
Xi, Jingyue
Hsu, Jer-En
Sarkar, Mrinal K. http://orcid.org/0000-0001-8505-4259
Chung, Yutein
Di Domizio, Jeremy http://orcid.org/0000-0002-6281-3918
Gilliet, Michel http://orcid.org/0000-0002-4609-3762
Ward, Nicole L. http://orcid.org/0000-0003-1907-2621
Maverakis, Emanual http://orcid.org/0000-0002-6294-6294
Klechevsky, Eynav http://orcid.org/0000-0001-6121-1571
Voorhees, John J. http://orcid.org/0000-0003-1856-785X
Elder, James T. http://orcid.org/0000-0003-4215-3294
Lee, Jun Hee http://orcid.org/0000-0002-2200-6011
Kahlenberg, J. Michelle http://orcid.org/0000-0002-4006-8945
Pellegrini, Matteo
Modlin, Robert L. http://orcid.org/0000-0003-4720-031X
Gudjonsson, Johann E. http://orcid.org/0000-0002-0080-0812
Article History
Received: 11 January 2022
Accepted: 26 May 2023
First Online: 12 June 2023
Competing interests
: J.E.G. has received research support from Almirall, AnaptysBio, Novartis, AbbVie, Eli Lilly, Kyowa Kirin, Galderma, BMS, Janssen. J.E.G. has served as advisor to Pfizer, AbbVie, Eli Lilly, Galderma, Almirall, AnaptysBio, Novartis, Sanofi, BMS. J.M.K. has received research support from Janssen, BMS, and Q32 bio. J.M.K. has served as an advisor to Eli Lilly, BMS, AstraZeneca, GlaxoSmithKline, Ventus Therapeutics, Admirex Pharmaceuticals, Aurinia Pharmaceuticals, and Provention Bio. The remaining authors declare no competing interests.